CytomX Therapeutics, Inc. (CTMX)
USD 0.46
(5.47%)
USD 0.46
(5.47%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 99.03 Million USD | 109.35% |
| 2022 | 47.3 Million USD | -25.77% |
| 2021 | 63.73 Million USD | -36.5% |
| 2020 | 100.36 Million USD | 74.58% |
| 2019 | 57.48 Million USD | -3.38% |
| 2018 | 59.5 Million USD | -16.92% |
| 2017 | 71.62 Million USD | 376.12% |
| 2016 | 15.04 Million USD | 95.06% |
| 2015 | 7.71 Million USD | 51.9% |
| 2014 | 5.07 Million USD | 471.73% |
| 2013 | 888 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 24.65 Million USD | -39.86% |
| 2024 Q1 | 40.99 Million USD | 56.95% |
| 2023 Q2 | 23.19 Million USD | 5.4% |
| 2023 FY | 99.03 Million USD | 109.35% |
| 2023 Q1 | 22 Million USD | 4152.12% |
| 2023 Q4 | 26.12 Million USD | 4.66% |
| 2023 Q3 | 24.95 Million USD | 7.61% |
| 2022 Q3 | 15.43 Million USD | -7.67% |
| 2022 Q1 | 17.13 Million USD | -6.07% |
| 2022 FY | 47.3 Million USD | -25.77% |
| 2022 Q4 | -543 Thousand USD | -103.52% |
| 2022 Q2 | 16.71 Million USD | -2.48% |
| 2021 Q4 | 18.24 Million USD | 3.74% |
| 2021 Q2 | 16.28 Million USD | 1.98% |
| 2021 FY | 63.73 Million USD | -36.5% |
| 2021 Q1 | 15.97 Million USD | -2.46% |
| 2021 Q3 | 17.58 Million USD | 7.98% |
| 2020 Q1 | 49.59 Million USD | 499.02% |
| 2020 Q4 | 16.37 Million USD | -7.95% |
| 2020 FY | 100.36 Million USD | 74.58% |
| 2020 Q2 | 16.6 Million USD | -66.51% |
| 2020 Q3 | 17.78 Million USD | 7.11% |
| 2019 Q2 | 9.01 Million USD | -69.43% |
| 2019 FY | 57.48 Million USD | -3.38% |
| 2019 Q3 | 10.71 Million USD | 18.85% |
| 2019 Q4 | 8.27 Million USD | -22.71% |
| 2019 Q1 | 29.48 Million USD | 157.04% |
| 2018 Q4 | 11.47 Million USD | -8.3% |
| 2018 FY | 59.5 Million USD | -16.92% |
| 2018 Q3 | 12.5 Million USD | -41.38% |
| 2018 Q2 | 21.33 Million USD | 50.44% |
| 2018 Q1 | 14.18 Million USD | -47.61% |
| 2017 Q3 | 24.14 Million USD | 175.87% |
| 2017 Q4 | 27.07 Million USD | 12.13% |
| 2017 FY | 71.62 Million USD | 376.12% |
| 2017 Q1 | 11.65 Million USD | 85.79% |
| 2017 Q2 | 8.75 Million USD | -24.89% |
| 2016 Q3 | 3.45 Million USD | 11.64% |
| 2016 Q2 | 3.09 Million USD | 39.18% |
| 2016 Q4 | 6.27 Million USD | 81.59% |
| 2016 FY | 15.04 Million USD | 95.06% |
| 2016 Q1 | 2.22 Million USD | 11.82% |
| 2015 FY | 7.71 Million USD | 51.9% |
| 2015 Q2 | 2.04 Million USD | 17.28% |
| 2015 Q1 | 1.74 Million USD | -6.39% |
| 2015 Q4 | 1.98 Million USD | 2.53% |
| 2015 Q3 | 1.93 Million USD | -5.09% |
| 2014 FY | 5.07 Million USD | 471.73% |
| 2014 Q2 | 666 Thousand USD | 4.88% |
| 2014 Q4 | 1.86 Million USD | -2.82% |
| 2014 Q1 | 635 Thousand USD | 0.0% |
| 2014 Q3 | 1.91 Million USD | 187.54% |
| 2013 FY | 888 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 17.792% |
| Jaguar Health, Inc. | 7.72 Million USD | -1182.224% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 15015.512% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1980880.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 93.475% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 17.297% |
| ContextLogic Inc. | 59 Million USD | -67.863% |
| MiMedx Group, Inc. | 266.84 Million USD | 62.885% |
| MEI Pharma, Inc. | 49.32 Million USD | -100.781% |
| AlloVir, Inc. | -398 Thousand USD | 24984.171% |
| Novavax, Inc. | 639.93 Million USD | 84.524% |
| Aptorum Group Limited | -1.11 Million USD | 8984.908% |
| Ardelyx, Inc. | 106.66 Million USD | 7.146% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 58.86% |
| Psyence Biomedical Ltd. | -240.00 USD | 41266350.0% |
| Vaxcyte, Inc. | -75 Million USD | 232.052% |
| Precigen, Inc. | 106 Thousand USD | -93333.019% |
| Pharming Group N.V. | 220.1 Million USD | 55.004% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -19130.874% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -9715.56% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 9.778% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 154.595% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 19265.896% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 176.466% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 318.509% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 550.443% |
| Acelyrin, Inc. | -115 Thousand USD | 86220.87% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 17444.834% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3791.353% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2344.804% |
| AbCellera Biologics Inc. | 38.02 Million USD | -160.458% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2164.173% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -82432.5% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -240.001% |
| Chimerix, Inc. | 324 Thousand USD | -30467.593% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -19867.54% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 120879.268% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 417.762% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 20229.878% |
| Elevation Oncology, Inc. | -39 Thousand USD | 254046.154% |
| Alkermes plc | 1.37 Billion USD | 92.795% |
| Fortress Biotech, Inc. | 57.85 Million USD | -71.191% |
| Fortress Biotech, Inc. | 57.85 Million USD | -71.191% |
| Agenus Inc. | 139.61 Million USD | 29.063% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -497.448% |
| Dyadic International, Inc. | 922.95 Thousand USD | -10630.619% |
| ImmuCell Corporation | 4.39 Million USD | -2152.789% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -370.248% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 193.325% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 56744.533% |
| Immix Biopharma, Inc. | -5468.00 USD | 1811347.257% |
| Incyte Corporation | 3.44 Billion USD | 97.122% |
| IO Biotech, Inc. | -756 Thousand USD | 13200.397% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 311.446% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 841.429% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 224230.986% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 200.837% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 180170.909% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -12249.002% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 18892.979% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -237.016% |
| NextCure, Inc. | -3.68 Million USD | 2788.355% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -420.081% |
| Onconetix, Inc. | -1.12 Million USD | 8886.557% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 441.891% |
| Opthea Limited | 21.72 Thousand USD | -455880.663% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 172864.54% |
| PureTech Health plc | -1.6 Million USD | 6278.353% |
| Pyxis Oncology, Inc. | -2 Million USD | 5051.95% |
| Seer, Inc. | 7.02 Million USD | -1309.407% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 985464.64% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1158.277% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2612.374% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -23258.255% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 4.861% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 26.784% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 202.155% |
| ChromaDex Corporation | 50.78 Million USD | -95.035% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 42789.224% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 227.631% |
| CRISPR Therapeutics AG | 240.95 Million USD | 58.897% |
| Precision BioSciences, Inc. | 40.47 Million USD | -144.71% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 200.892% |
| Innoviva, Inc. | 261.06 Million USD | 62.063% |
| Summit Therapeutics Inc. | -2.05 Million USD | 4931.171% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2162.197% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -359.684% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 83683.563% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 69212.567% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -16162.562% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 68.426% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -3747.669% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 195289.2% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1495.309% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 20970.307% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 952398.077% |
| Soligenix, Inc. | 97.31 Thousand USD | -101675.75% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1016.264% |
| Kura Oncology, Inc. | -849 Thousand USD | 11765.371% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 247.59% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 67473.469% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Autolus Therapeutics plc | -4.86 Million USD | 2134.909% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -139.306% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 59051.786% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -4.556% |
| GRI Bio, Inc. | 10.84 Million USD | -813.56% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3799.195% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1240.083% |
| IGM Biosciences, Inc. | -211.66 Million USD | 146.792% |
| INmune Bio, Inc. | 155 Thousand USD | -63796.129% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -59.898% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 6675.024% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 15373.096% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 338417.278% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -24536.567% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 5061.874% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 31741.853% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -4.846% |
| Verastem, Inc. | -62 Thousand USD | 159840.323% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -3967.31% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 38045.977% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3171.853% |
| Histogen Inc. | 3.76 Million USD | -2527.726% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -17088.929% |
| Surrozen, Inc. | -27.23 Million USD | 463.713% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1937.799% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 8319.823% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 486.162% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -393.911% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 5002069.697% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1532.577% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 147630.947% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 36.018% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -67827.984% |
| Apollomics, Inc. | 127 Thousand USD | -77883.465% |
| Amarin Corporation plc | 165.54 Million USD | 40.173% |
| Mesoblast Limited | -9.81 Million USD | 1109.058% |
| Turnstone Biologics Corp. | 16.5 Million USD | -500.018% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 189.637% |
| Synaptogenix, Inc. | -6347.00 USD | 1560506.491% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 194294.118% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 38.624% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 94.365% |
| Better Therapeutics, Inc. | -2.72 Million USD | 3729.132% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 188.301% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 70.706% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 868253.927% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1682.093% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9038.538% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1253.361% |
| Insmed Incorporated | 239.63 Million USD | 58.671% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2667.999% |
| OmniAb, Inc. | 14.66 Million USD | -575.251% |
| Alector, Inc. | -95.05 Million USD | 204.193% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 21.16% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 327.87% |
| Zai Lab Limited | 170.9 Million USD | 42.05% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -20.961% |
| Aura Biosciences, Inc. | -1.29 Million USD | 7747.799% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -76083.846% |
| Immunic, Inc. | -111 Thousand USD | 89324.324% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -524.694% |
| Veracyte, Inc. | 248.14 Million USD | 60.089% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.417% |
| FibroGen, Inc. | 128.9 Million USD | 23.168% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 17560206.383% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 948.89% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 97.086% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -25359.897% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 72.129% |
| TG Therapeutics, Inc. | 219.1 Million USD | 54.799% |
| Galecto, Inc. | -830 Thousand USD | 12032.41% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 7250.83% |
| Fortrea Holdings Inc. | 424 Million USD | 76.642% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 214.938% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 17567.196% |
| XBiotech Inc. | -1.74 Million USD | 5778.842% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9038.538% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 313.12% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 231.118% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -34.925% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -489.413% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 74.543% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 299.486% |
| Vaxxinity, Inc. | -2.23 Million USD | 4533.259% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 69.69% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 974.606% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -305.051% |
| NexImmune, Inc. | -1.02 Million USD | 9762.605% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1833955.556% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1493.805% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.124% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 148302.074% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 2889.045% |
| Ainos, Inc. | -253.73 Thousand USD | 39132.763% |
| Pluri Inc. | 322 Thousand USD | -30657.453% |
| Prothena Corporation plc | -129.2 Million USD | 176.655% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -96.413% |
| Celularity Inc. | 6.75 Million USD | -1366.158% |
| Rallybio Corporation | -150 Thousand USD | 66126.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 403.735% |
| MeiraGTx Holdings plc | 287 Thousand USD | -34408.362% |
| Omeros Corporation | -69.77 Million USD | 241.932% |
| Humacyte, Inc. | -76.55 Million USD | 229.378% |
| Immunocore Holdings plc | 248.39 Million USD | 60.128% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 752.904% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -58.762% |
| Blueprint Medicines Corporation | 236.58 Million USD | 58.138% |
| CalciMedica, Inc. | -58 Thousand USD | 170856.897% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 7045.231% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -240.867% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3582.384% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 420.878% |
| Pulmatrix, Inc. | -8.22 Million USD | 1304.854% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 8564.872% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 24921.805% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 124.835% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3468.221% |
| Cytokinetics, Incorporated | -322.59 Million USD | 130.701% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -11388.044% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 29143.695% |
| Vor Biopharma Inc. | -3.49 Million USD | 2936.168% |
| Roivant Sciences Ltd. | 109.23 Million USD | 9.334% |
| Evogene Ltd. | 1.39 Million USD | -6979.271% |
| ProKidney Corp. | -3.16 Million USD | 3225.245% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 325.54% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1344.349% |
| CorMedix Inc. | -205.56 Thousand USD | 48279.625% |
| BioLineRx Ltd. | 1.1 Million USD | -8838.538% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 225.89% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 300218.182% |
| Atai Life Sciences N.V. | -5000.00 USD | 1980880.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 81373.439% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 103265.625% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 7230.238% |
| Sagimet Biosciences Inc. | 2 Million USD | -4851.95% |
| MediciNova, Inc. | 979.7 Thousand USD | -10009.063% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 217.458% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 104842.214% |
| GeoVax Labs, Inc. | -20.72 Million USD | 577.97% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 59.499% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2457.51% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 88.647% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1233.679% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 32048.065% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 825425.0% |
| Absci Corporation | -41.84 Million USD | 336.658% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1980880.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 229.678% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4124.34% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 53.663% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 10624.867% |
| Allakos Inc. | -6.14 Million USD | 1712.75% |
| Imunon, Inc. | -720 Thousand USD | 13855.321% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 243.543% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 79.189% |
| BioAtla, Inc. | -103.73 Million USD | 195.477% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 868253.927% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 55739.888% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 140.787% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 31945.338% |
| XOMA Corporation | 3.86 Million USD | -2465.113% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 241.313% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -569.454% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4247.362% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -694.856% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 341613.793% |
| Viridian Therapeutics, Inc. | -1 Million USD | 9925.298% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -761838361.538% |
| Akari Therapeutics, Plc | -4000.00 USD | 2476075.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 84.45% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -50765.398% |
| UroGen Pharma Ltd. | 73.35 Million USD | -35.019% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 471.016% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -852949.096% |
| Orgenesis Inc. | -5.72 Million USD | 1829.939% |
| Entera Bio Ltd. | -56 Thousand USD | 176955.357% |
| GH Research PLC | -315 Thousand USD | 31540.952% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 52501.587% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 18964.571% |
| Xencor, Inc. | -85.26 Million USD | 216.161% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 44918.692% |
| Replimune Group, Inc. | -2.65 Million USD | 3830.282% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 9991.674% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 44.311% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -50765.398% |
| Portage Biotech Inc. | -54 Thousand USD | 183505.556% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 104842.214% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 26370.292% |
| OncoCyte Corporation | 413 Thousand USD | -23880.387% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2203414.794% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 44612262.162% |
| Purple Biotech Ltd. | -196 Thousand USD | 50630.102% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1004.36% |
| scPharmaceuticals Inc. | 9.78 Million USD | -912.462% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1048.199% |
| HilleVax, Inc. | -2.15 Million USD | 4693.646% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 102202.062% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 660183.978% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 14926.198% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 430704.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1319536.303% |
| Savara Inc. | -44.26 Million USD | 323.756% |
| Curis, Inc. | 9.81 Million USD | -909.469% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3476.032% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 79465.804% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 5828.109% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 43538.158% |
| BeiGene, Ltd. | 2.07 Billion USD | 95.236% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3642.294% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 124.781% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -74.709% |
| Erasca, Inc. | -3.73 Million USD | 2753.778% |
| bluebird bio, Inc. | -4.03 Million USD | 2557.543% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 351078.099% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.799% |
| DBV Technologies S.A. | 15.72 Million USD | -529.699% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 351078.099% |
| Moderna, Inc. | 2.15 Billion USD | 95.404% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 10923.934% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1137.06% |
| Molecular Templates, Inc. | 50.39 Million USD | -96.525% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 18577.425% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 25.973% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1691.755% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 351.732% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 189.122% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 2860.284% |
| MacroGenics, Inc. | 50.52 Million USD | -96.012% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1724.123% |
| Prime Medicine, Inc. | -147.9 Million USD | 166.961% |
| Aditxt, Inc. | -111.66 Thousand USD | 88796.937% |
| Adagene Inc. | 18.11 Million USD | -446.83% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -20194.877% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 29.36% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 37.252% |
| SciSparc Ltd. | 2.19 Million USD | -4409.973% |
| Vericel Corporation | 135.57 Million USD | 26.949% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 395481.053% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 319766.258% |
| Generation Bio Co. | -73.91 Million USD | 233.998% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 22763.387% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -81.327% |
| Invivyd, Inc. | -2.02 Million USD | 4983.58% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 132.921% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 95847.211% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -2.772% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -0.764% |
| ADMA Biologics, Inc. | 88.21 Million USD | -12.266% |
| Clene Inc. | 533 Thousand USD | -18481.426% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -310.794% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 10448.903% |
| GeoVax Labs, Inc. | -20.72 Million USD | 577.97% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -4881.841% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 51068.011% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -98.854% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1496.489% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 11946.77% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -18.73% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -135362.031% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -86.297% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 157.186% |
| Trevena, Inc. | 1.45 Million USD | -6706.804% |
| Surrozen, Inc. | -27.23 Million USD | 463.713% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 28156.374% |
| Cingulate Inc. | -582.91 Thousand USD | 17090.211% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 319580.645% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 602.762% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1308409.115% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 11341.657% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 85.451% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 10124.19% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 175881.832% |
| Kronos Bio, Inc. | 1.37 Million USD | -7118.586% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 284.547% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 34017.466% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 20381.827% |
| ImmunityBio, Inc. | -17.89 Million USD | 653.6% |
| Korro Bio, Inc. | -3.63 Million USD | 2828.347% |
| Kineta, Inc. | 5.43 Million USD | -1722.916% |
| BioVie Inc. | -229.37 Thousand USD | 43277.389% |
| Codexis, Inc. | 57.33 Million USD | -72.74% |
| Celularity Inc. | 6.75 Million USD | -1366.158% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2367.954% |
| Celcuity Inc. | -142.77 Thousand USD | 69468.644% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -195667.938% |
| Cibus, Inc. | 1.42 Million USD | -6864.768% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 26581.016% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 532.126% |
| IN8bio, Inc. | -2.5 Million USD | 4059.976% |
| Kodiak Sciences Inc. | -25.94 Million USD | 481.697% |
| Annexon, Inc. | -3.26 Million USD | 3131.497% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 4945.352% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 337.293% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -15374.844% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 87.278% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 42.737% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5312.579% |
| Arcellx, Inc. | 108.27 Million USD | 8.534% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 405.969% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -25.043% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 568.225% |
| Moolec Science SA | -143.3 Thousand USD | 69210.638% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 334.035% |
| Geron Corporation | -123.5 Million USD | 180.192% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -2913.051% |
| Royalty Pharma plc | 1.79 Billion USD | 94.479% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 241.303% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2742043.522% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -42701.578% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 188.893% |
| Humacyte, Inc. | -76.55 Million USD | 229.378% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 10534.23% |
| 89bio, Inc. | -273 Thousand USD | 36378.022% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 7978.998% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 11779.127% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 80619.512% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -8750.67% |
| Notable Labs, Ltd. | 113 Thousand USD | -87545.133% |
| Liquidia Corporation | 14.6 Million USD | -578.349% |
| Mustang Bio, Inc. | -2.22 Million USD | 4551.191% |
| Immunovant, Inc. | -231 Thousand USD | 42974.026% |
| Quantum-Si incorporated | 488 Thousand USD | -20194.877% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 278.259% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 330230.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5218.958% |
| Acasti Pharma Inc. | -11 Thousand USD | 900454.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 48502.137% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 15373.096% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 159.124% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -8629.133% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 26094.488% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5158.172% |
| PepGen Inc. | -1.18 Million USD | 8464.78% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 78083.465% |
| United Therapeutics Corporation | 2.07 Billion USD | 95.216% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 532.541% |
| Solid Biosciences Inc. | -76.56 Million USD | 229.356% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 120026.619% |
| Immuneering Corporation | -764.13 Thousand USD | 13060.879% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -149361.246% |
| Belite Bio, Inc | -399 Thousand USD | 24921.805% |
| XOMA Corporation | 3.86 Million USD | -2465.113% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 594.305% |
| Bionomics Limited | -434.44 Thousand USD | 22896.462% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 9321.508% |
| uniQure N.V. | 2.21 Million USD | -4371.287% |
| Cassava Sciences, Inc. | -89.42 Million USD | 210.753% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 207.57% |
| Forte Biosciences, Inc. | -9000.00 USD | 1100533.333% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 11960.958% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 22763.387% |
| Altimmune, Inc. | -65.37 Million USD | 251.498% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 72.643% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 9321.508% |
| Compugen Ltd. | 31.45 Million USD | -214.859% |
| Peak Bio, Inc. | 367.76 Thousand USD | -26829.676% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -303.977% |
| Benitec Biopharma Inc. | 108 Thousand USD | -91602.778% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 127073.077% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 8332.668% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 5535.73% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 83326.05% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 8332.668% |
| Instil Bio, Inc. | -4.75 Million USD | 2182.401% |
| argenx SE | 1.1 Billion USD | 91.065% |
| Immunome, Inc. | -8.9 Million USD | 1211.923% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5340.159% |
| Verona Pharma plc | -679.62 Thousand USD | 14672.617% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 56693.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4252.579% |
| CervoMed Inc. | -1.29 Million USD | 7755.916% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4214.624% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2173.247% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -3908.053% |
| Moolec Science SA | -143.3 Thousand USD | 69210.638% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 24372.48% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3807.204% |
| AnaptysBio, Inc. | 14.78 Million USD | -570.043% |
| Design Therapeutics, Inc. | -537 Thousand USD | 18543.017% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 23294.145% |
| NeurAxis, Inc. | 2.15 Million USD | -4492.146% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4515.051% |
| Lumos Pharma, Inc. | 2 Million USD | -4834.679% |
| Achilles Therapeutics plc | -4.73 Million USD | 2193.287% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 56693.714% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 93820.369% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -212.833% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -11388.044% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 9696.802% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 317.439% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -230223.256% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 12148.54% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 752790.378% |
| Palisade Bio, Inc. | 246 Thousand USD | -40159.756% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 300218.182% |
| Beam Therapeutics Inc. | -59.67 Million USD | 265.972% |
| Neurogene Inc. | -3.26 Million USD | 3136.143% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 28.92% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2782.53% |
| Sesen Bio, Inc. | 40 Million USD | -147.598% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 33446.465% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2559.352% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1135.323% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -603.402% |
| Athira Pharma, Inc. | -969 Thousand USD | 10320.743% |
| Vaccinex, Inc. | -16 Million USD | 718.839% |
| HCW Biologics Inc. | -574.82 Thousand USD | 17329.448% |
| XOMA Corporation | 3.86 Million USD | -2465.113% |
| Nektar Therapeutics | 53.47 Million USD | -85.196% |
| Arvinas, Inc. | 71.8 Million USD | -37.937% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 218.665% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 257.768% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 30857.453% |
| Rezolute, Inc. | -36 Thousand USD | 275208.333% |
| Clene Inc. | 533 Thousand USD | -18481.426% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 7713417.757% |
| BeyondSpring Inc. | 1.75 Million USD | -5556.139% |
| Synlogic, Inc. | -1.92 Million USD | 5247.557% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 267772.973% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1664.103% |
| Peak Bio, Inc. | 367.76 Thousand USD | -26829.676% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 622.275% |
| Krystal Biotech, Inc. | 47.6 Million USD | -108.043% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 29.805% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1870.925% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 3925.053% |
| MannKind Corporation | 136.19 Million USD | 27.279% |
| Ikena Oncology, Inc. | -50.49 Million USD | 296.148% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 8.983% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2358.586% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 39401.19% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1980880.0% |
| Legend Biotech Corporation | 140.92 Million USD | 29.724% |
| Mural Oncology plc | -2.56 Million USD | 3958.161% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 18074.41% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 99139.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -377.204% |
| REGENXBIO Inc. | 53.02 Million USD | -86.764% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1948.794% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 51582.261% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 5818.187% |
| Vaxart, Inc. | -60.76 Million USD | 262.992% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 37788.941% |
| Cellectis S.A. | 18 Thousand USD | -550116.667% |
| Longeveron Inc. | 221 Thousand USD | -44714.027% |
| Repare Therapeutics Inc. | -80.07 Million USD | 223.691% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 90.939% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 7753.709% |
| Revolution Medicines, Inc. | -399.66 Million USD | 124.781% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 283068.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -202020.408% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.849% |
| Denali Therapeutics Inc. | -93.34 Million USD | 206.1% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 395481.053% |
| Veru Inc. | 7.56 Million USD | -1209.013% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 65688.742% |
| Cingulate Inc. | -582.91 Thousand USD | 17090.211% |
| Passage Bio, Inc. | -3.72 Million USD | 2761.623% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 822409.864% |
| Exicure, Inc. | -1.42 Million USD | 7059.874% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 25958.747% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3564.04% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 19418.087% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -45.376% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 66299.443% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 267.279% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -25229.668% |
| OmniAb, Inc. | 14.66 Million USD | -575.251% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -395.368% |
| Lipocine Inc. | -2.85 Million USD | 3574.056% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 5473.793% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1836.004% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 6675.024% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -31.498% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 152467.692% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -17.49% |
| Ocugen, Inc. | -33.53 Million USD | 395.313% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3232.163% |
| Q32 Bio Inc. | 578 Thousand USD | -17034.775% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 37473.208% |
| Alumis Inc. Common Stock | -1.28 Million USD | 7813.318% |
| Equillium, Inc. | 35.95 Million USD | -175.43% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 5901.933% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -19680.937% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2395818.433% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 38338.996% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -23329.427% |
| Dominari Holdings Inc. | 2.03 Million USD | -4757.234% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 54080.738% |
| vTv Therapeutics Inc. | -13.59 Million USD | 828.496% |
| Bio-Techne Corporation | 773.07 Million USD | 87.189% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -471.852% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 78.507% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 8572.113% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 513.007% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -746.704% |
| Nkarta, Inc. | -5.86 Million USD | 1787.494% |
| BioCardia, Inc. | -7.24 Million USD | 1466.244% |
| Iterum Therapeutics plc | -1.75 Million USD | 5759.371% |